Skip to main content
Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.290
+0.170 (15.18%)
At close: Dec 20, 2024, 4:00 PM
1.280
-0.010 (-0.78%)
After-hours: Dec 20, 2024, 7:59 PM EST

Actinium Pharmaceuticals Revenue

Actinium Pharmaceuticals had revenue of $81.00K in the twelve months ending September 30, 2024. In the year 2023, Actinium Pharmaceuticals had annual revenue of $81.00K, down -92.14%.

Revenue (ttm)
$81.00K
Revenue Growth
-92.14%
P/S Ratio
n/a
Revenue / Employee
$1,653
Employees
49
Market Cap
40.24M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202381.00K-949.00K-92.14%
Dec 31, 20221.03M-114.00K-9.97%
Dec 31, 20211.14M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
FibroGen 180.02M
Precision BioSciences 75.10M
NEXGEL 6.73M
Moolec Science 5.63M
Marker Therapeutics 5.40M
SAB Biotherapeutics 1.51M
VYNE Therapeutics 493.00K
Revenue Rankings

ATNM News

More News